YMRC
HAE icon

Yorktown Management & Research Company’s Haemonetics HAE Stock Holding History

Yorktown Management & Research Company’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$330K Buy
+4,400
New +$283K 0.2% 192
2025
Q3 		– Sell
-3,100
Closed -$231K – 222
2025
Q2 		$231K Buy
+3,100
New +$205K 0.22% 199
2025
Q1 		– Sell
-4,000
Closed -$312K – 218
2024
Q4 		$312K Hold
4,000
– – 0.3% 167
2024
Q3 		$322K Buy
+4,000
New +$323K 0.33% 158

Other funds holding HAE

RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Yorktown Management & Research Company's HAE Position: Q2 2026 in Review

Yorktown Management & Research Company opened a new position in Haemonetics (HAE) in Q2 2026: 4,400 shares worth $330K. The stake represents 0.2% of the portfolio and ranks #192 among its holdings. This is a return to the name: Yorktown Management & Research Company previously reported a position in HAE as recently as Q2 2025.

Yorktown Management & Research Company first reported a position in HAE in Q3 2024 and has held it in 4 quarters since. 83 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Yorktown Management & Research Company held 4,400 shares of Haemonetics worth $330K as of Q2 2026.
  • Haemonetics was a new Yorktown Management & Research Company position in Q2 2026.
  • Haemonetics made up 0.2% of Yorktown Management & Research Company's portfolio in Q2 2026, its #192 holding.
  • Yorktown Management & Research Company first reported a position in Haemonetics in Q3 2024 and has held it in 4 quarters since.
  • 83 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Yorktown Management & Research Company's 13F filing for Q2 2026, filed 23 Jul 2026.